Treatment group:PD-1 inhibitor + chemotherapy
Sponsors
The Fifth Affiliated Hospital of Sun Yat-Sen University
Conditions
lung cancer
Early Phase 1
An exploratory clinical study of PD-1 inhibitor combined with chemotherapy in the treatment of advanced non-small cell lung cancer with EGFR mutation positive and T790M negative after failure of TKI combined with antiangiogenic drugs
RecruitingChiCTR2000039514
Start: 2020-10-31Updated: 2021-02-01
Exploratory clinical study of PD-1 inhibitor combined with chemotherapy (albumin paclitaxel combined with carboplatin for three weeks) in the treatment of advanced non-small cell lung cancer
Active, not recruitingChiCTR2100045209
Start: 2021-04-08Updated: 2021-11-16